Literature DB >> 36149932

Prediction models for the prediction of unplanned hospital admissions in community-dwelling older adults: A systematic review.

Jet H Klunder1,2, Sofie L Panneman1, Emma Wallace3, Ralph de Vries4, Karlijn J Joling2,5, Otto R Maarsingh1,2, Hein P J van Hout1,2,5.   

Abstract

BACKGROUND: Identification of community-dwelling older adults at risk of unplanned hospitalizations is of importance to facilitate preventive interventions. Our objective was to review and appraise the methodological quality and predictive performance of prediction models for predicting unplanned hospitalizations in community-dwelling older adults. METHODS AND
FINDINGS: We searched MEDLINE, EMBASE and CINAHL from August 2013 to January 2021. Additionally, we checked references of the identified articles for the inclusion of relevant publications and added studies from two previous reviews that fulfilled the eligibility criteria. We included prospective and retrospective studies with any follow-up period that recruited adults aged 65 and over and developed a prediction model predicting unplanned hospitalizations. We included models with at least one (internal or external) validation cohort. The models had to be intended to be used in a primary care setting. Two authors independently assessed studies for inclusion and undertook data extraction following recommendations of the CHARMS checklist, while quality assessment was performed using the PROBAST tool. A total of 19 studies met the inclusion criteria. Prediction horizon ranged from 4.5 months to 4 years. Most frequently included variables were specific medical diagnoses (n = 11), previous hospital admission (n = 11), age (n = 11), and sex or gender (n = 8). Predictive performance in terms of area under the curve ranged from 0.61 to 0.78. Models developed to predict potentially preventable hospitalizations tended to have better predictive performance than models predicting hospitalizations in general. Overall, risk of bias was high, predominantly in the analysis domain.
CONCLUSIONS: Models developed to predict preventable hospitalizations tended to have better predictive performance than models to predict all-cause hospitalizations. There is however substantial room for improvement on the reporting and analysis of studies. We recommend better adherence to the TRIPOD guidelines.

Entities:  

Mesh:

Year:  2022        PMID: 36149932      PMCID: PMC9506609          DOI: 10.1371/journal.pone.0275116

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Background

In the Netherlands, approximately one in five older adults is admitted to hospital each year [1]. Moreover, hospital admission rates in ED patients aged 65 years and older are twice as high as those in ED patients aged <65 years [2]. When hospitalized, older adults are at high risk of experiencing adverse events such as hospital-associated infections and delirium, causing lengthy hospital stays [3, 4]. In addition, hospitalizations pose a significant risk to the functional ability of older adults, whereas 30% of older patients experiences loss of independence in activities of daily living (ADL) after hospital admission [5]. Older adults account for a large proportion of hospitalized adults, which is likely to increase with the aging population, causing overcrowding of emergency departments (EDs) and hospital wards [6, 7]. Overcrowded EDs have been described as a global health problem having negative effects on patients (e.g. treatment delay), healthcare staff (e.g. stress) and the healthcare system (e.g. increased length of stay in ED as well as in hospital wards) [8]. Taking into account that a large proportion of hospitalizations and ED visits in older adults is considered preventable [9], it seems crucial to timely identify older adults at risk of hospitalization to assess possible preventive measures. This would not only increase patient’s health and quality of life, but also relieve pressure on secondary and tertiary care, resulting in a decrease in overall health care costs [10]. Prediction models can be used to identify community-dwelling older adults at risk for unplanned hospital admissions. By defining and combining important predictors of future emergency care use, preventive interventions can be targeted at high risk individuals [11]. Several prediction models for the prediction of unplanned hospitalizations have been developed and two systematic reviews on this topic have previously been published. However, these reviews included studies in adults of all ages or only included easy to apply case-finding instruments [12, 13]. Furthermore, these reviews were published over seven years ago. In an era of personalized and precision medicine, interest in and the number of prediction models have grown rapidly [14, 15]. Moreover, with the emergence of big data, attention has grown towards different modelling techniques beside traditional regression methods, such as machine learning (ML). Despite guidelines as the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) [16], quality of methodology and reporting of clinical prediction model studies is however often insufficient [17, 18]. We carried out a systematic review of validated prediction models for predicting unplanned hospital admissions in community-dwelling older adults (≥65 years). Our objective was to describe characteristics of the models’ development, the predictors included in the final models, the predictive performance, and to appraise methodological quality of the included models.

Methods

This review is reported according to the Preferred Reported Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement [19]. The study protocol has been registered on the International Prospective Register of Systematic Reviews (PROSPERO, registration number: CRD42020207305).

Search strategy, study selection and data-extraction

We conducted systematic searches in the bibliographic databases PubMed, Embase.com and CINAHL (Ebsco) in January 2021, in collaboration with a medical information specialist. The following terms were used (including synonyms and closely related words) as index terms or free-text words: "Hospital admission", "Patient admission", "Unplanned", "Aged", "Older adults", "Prediction". We applied a validated search filter for finding clinical prediction model studies [20]. The full search strategies are provided in S1 File. As previously mentioned, two systematic reviews on this topic have been published. Wallace et al. carried out a systematic literature search in February 2014 on risk prediction models to predict emergency admissions in community-dwelling adults [13]. O’Caoimh et al. reviewed short case-finding instruments, published up and until November 2014, for community-dwelling older adults (> 50 years) at risk for multiple adverse outcomes, of which hospitalization was one [12]. To provide a complete overview of available prediction models our search was restricted to August 2013 through January 2021 and we added the models described in the previous reviews that fulfilled the eligibility criteria of this systematic review. The references of the identified articles were searched for relevant publications. Duplicate articles were excluded. Studies were included if they met the following criteria: Population: community-dwelling older adults, aged 65 years and over Intervention: prognostic prediction models derived from retrospective or prospective cohort studies and containing at least one validation cohort Comparator: not applicable Outcome: one or more unplanned hospitalizations (defined as unplanned overnight stay in hospital). Studies that had admission to the ED as part of their outcome of interest (i.e. combined endpoints) were also included Timing: admission to hospital within any time period Setting: prediction models intended to be used in primary care We excluded studies if the prediction models: were contingent on an index hospital admission or ED visit (i.e. readmission models) studied hospitalizations for specific conditions (e.g. falls or congestive heart failure) as primary outcome were intended to be used in the ED were developed in specific populations (e.g. patients in palliative care or with psychiatric conditions), with the exception of participants with sensory impairments, because of high prevalence in the older population [21] Studies that assessed risk factors only and did not build a prediction model, studies that were not developed to specifically predict unplanned hospitalizations, such as models that identify frailty, and studies published in languages other than English, Dutch, German, French, Italian and Spanish were also excluded. All records were deduplicated in Endnote v9.1, and consequently exported to the Rayyan web app for title and abstract screening and study selection [22]. After study selection, data extraction was performed using a standardized form following the recommendations of the Checklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS; S2 File) [23]. Both selection and data extraction phases were independently conducted by two reviewers (JK and SP). Any disagreements were resolved through a consensus procedure or by third review (OM, KJ, HvH). Additional data were sought from authors, when necessary. Due to heterogeneity of the prediction models, meta-analysis was not possible. We therefore narratively summarized each unique prediction model on study population, predictors, number of outcomes and predictive performance. For clarity reasons, regression models and machine learning models were presented separately. Predictive performance was assessed as model discrimination using the area under the ROC curve (AUC) with 95% confidence intervals. Higher AUC values indicate better discriminatory ability. An AUC of 0.7–0.8 reflects fair discrimination, whereas a model with AUC ≥ 0.8 represents good discrimination [24].

Methodological quality assessment

The Prediction model Risk of Bias ASsessment Tool (PROBAST; S2 File) was used to assess risk of bias and applicability, of which the latter addresses whether the primary study matches the review question [25]. PROBAST rates study methodology and applicability to the review question as being at “high”, “low” or “unclear” risk of bias based on a predetermined set of questions and scoring guide [26]. In addition, we calculated the number of events per variable (EPV) for each model. The number of EPV is the number of outcome events divided by the number of candidate predictors assessed in the multivariable modelling [27]. Studies with an EPV <10 are generally subject to overfitting, therefore an EPV of >20 is recommended. Prediction models developed using ML techniques often require higher EPVs (often >200) to minimize overfitting [26].

Results

Study selection

The literature searches yielded a total of 16,098 citations (Fig 1). After removing duplicates 8,820 references remained. Additionally, twenty-three articles were identified by checking the reference lists of relevant studies. Full texts were retrieved for 170 studies of which ten met all inclusion criteria. Additionally, a total of nine studies were included from the previously published systematic reviews (Tables 1 and 2).
Fig 1

PRISMA flow diagram of included risk prediction models.

Table 1

Prediction models developed using regression methods.

First author + referenceAcronymModelling methodPopulation + SettingDerivation, nValidation, nData used for final modelOutcomeNumber of outcome events, n (%)AUC (95% CI)Predictors in final model
Boult [28]Pra (Probability of repeated admissions)Logistic regressionNon-institutionalized patients aged ≥70, United States, 1984–199029422934 (split sample)Predictors = Self-report data from longitudinal study of agingOutcome = Medicare program records≥2 hospital admissions in 4 yearsInternal validation = 669 (22.7%)Internal validation = 0.611. Age2. Sex3. Self-rated health4. Availability of informal caregiver5. Diagnosis of coronary artery disease6. Diagnosis of diabetes7. Hospital admission in previous year8. ≥6 doctor visits in previous year
Deardorff [29]LASSOLogistic regressionCommunity dwelling Medicare beneficiaries with hearing and/or vision impairment aged ≥65, United States, 1999–200615,999N/A bootstrap validation in full cohortPredictors = Medicare Current Beneficiary Survey dataOutcome = Claims dataHospital admission in 12 monthsDerivation = 2567 (16.0%)Validation = N/ADerivation = 0.72Validation = 0.721. Number of inpatient admissions in previous year2. Number of ED visits in previous year3. ADL difficulty level4. Poor self-rated health5. History of myocardial infarction6. History of stroke7. History of non-skin cancer
Freedman [30]Logistic regressionPatients with a Kaiser Permanente health plan aged ≥81, United States, 199318731872 (split sample)Predictors = Self-administered questionnaireOutcome = Health plans computerized records systemHospital admission in 4.5 monthsDerivation = NRValidation = NRDerivation = 0.69Validation = 0.631. Heart trouble2. Limited physical independence3. Interaction of 1. and 2.4. Need help preparing meals5. Diabetes
Inouye [31]Logistic regressionPatients aged ≥70 in 2 primary care clinics, United States, 2003–200619321987 (split sample)Predictors and outcome = Administrative dataUnplanned hospital admission within 12 monthsDerivation = 299 (15%)Validation = 328 (17%)Derivation = 0.72Validation = 0.731. CCI ≥212. Hospitalization in previous year3. Primary care visits ≥6 in previous year4. Age ≥855. Unmarried
Kan [32]2Full model approachPatients enrolled in a local Medicare Advantage Health Maintenance Organization plan, United States, 2011–201316,705NRTemporal validationThree models1. Based on claims data2. Based on EHR-structured data3. Based on EHR-structured and EHR-unstructured data≥1 hospitalization within 12 monthsPredictive model = 3174 (19.0%)Predictive model =Model 1 = 0.70Model 2 = 0.70Model 3 = 0.711. Age2. Sex3. Race4. Number of major ADGs2a5. Number of hospital dominant conditions2b6. Number of frailty risk factors2c
Kim [46]Logistic regressionInsured adults aged ≥ 65, South Korea, 2011–2012Total sample: 113,612NR (split sample + bootstrap)Predictors and outcome = Routinely collected claims dataPotentially avoidable hospitalization within 12 monthsTotal sample = 2856 (2.5%)Derivation = 0.77 (0.76–0.79)Validation = 0.78 (0.77–0.80)1. Age2. Living area3. Insurance4. No. chronic conditions5. Polypharmacy6. Disability7. Hospitalization in past year8. Total health expenditures in past year
Kurichi [33]Logistic regressionMedicare Beneficiaries aged ≥65, United States, 2001–200715,6067801 (split sample)Predictors = routinely collected survey dataOutcome = claims filesTwo models due to collinearity:1. ADL limitation2. IADL limitationHospital admission within 3 yearsNRDevelopment =ADL limitation: 0.67iADL limitation: 0.67Validation =ADL limitation: 0.67iADL limitation: 0.6722/23 variables:31. Sociodemographics (n = 6)2. Self-reported health conditions (n = 13)3. Vision impairment4. Smoking5. (I)ADL stage6. Proxy responded (IADL model only)
Lin [45]Logistic regressionSubjects aged ≥65 with at least 1 outpatient visit in 2008, Taiwan, 2008–2009133,72644,560 (split sample)Predictors and outcome = claims files from national health insurance instituteHospital admission within 1 yearDerivation = 25,541 (19.1%)Validation = 8511 (19.1%)Development = 0.64 (0.64–0.65)Validation = 0.64 (0.63–0.65)1. Age2. Education3. COPD4. Heart disease5. Diabetes6. Cancer (with or without metastases)7. Chronic kidney disease8. ED visit in past year9. Received home care in past year
López-Aguilà [44]Logistic regressionPatients in primary care aged ≥65, Spain, 2006–200928,430NRPredictors = Clinical records of primary care centers, pharmacy database, and hospital discharge recordsOutcome = Hospital discharge recordsUnplanned hospital admission in 12 monthsDerivation = 2103 (7.3%)Validation = NRDerivation = 0.78Validation = 0.761. Sex2. Age3. COPD4. Heart failure5. 5 or more concurrent diagnoses6. 4 or more prescribed drugs7. 2 or more emergency admissions48. 2 or more planned admissions49. 9 or more days of cumulative stay4
Lyon [40]EARLI (Emergency Admission Risk Likelihood IndexLogistic regressionPatients in general practices aged ≥75, England, 2002–20033032500 (split sample + bootstrap)Predictors = QuestionnaireOutcome = Hospital Episodes Statistics dataUnplanned hospital admission in 12 monthsDerivation = 696 (23.0%)Validation = NRDerivation = 0.70 (0.67–0.72)Validation =• Bootstrap validation = 0.69• Split sample validation = 0.67 (0.63–0.71)1. Heart problems2. Leg ulcers3. Get out of the house without help4. Problems with memory or get confused5. Emergency hospital admission in last 12 months6. Overall state of health
Marcusson [43]Logistic regression / LASSOPatients in primary care aged ≥75, Sweden, 2015–201720,364Internal validation = 20,364 (split sample)External validation:1) 51,104 (sample with ages 65–74)2) 38,121 (different time period)Predictors and outcome = computerized information system of the County Council of Östergötland.Unplanned hospital admission within 12 monthsDerivation = 4130 (20.3%)Validation = Split sample: 4037 (19.8%)External validation: NRDerivation: NRInternal validation: 0.69 (0.68–0.70)External validation:1) 0.68 (0.67–0.69)2) 0.68 (0.67–0.69)38 predictors =1. Sex2. Age3. Number of non-physician visits4. Number of physician visits, 5. Number of previous in-ward hospital stays6. Number of ED visits7. Signs/symptoms and medical diagnoses (n = 32)
Mazzaglia [38]Logistic regressionPersons in primary care aged ≥65, Italy, 2003–200424702926 (external validation)Predictors = Questionnaire answered by primary care physician, registries of the regional health system of TuscanyOutcome = Registries of the regional health system of TuscanyHospitalization in 15 monthsDerivation = 445 (18.0%)Validation = 504 (17.2%)Derivation = 0.68 (0.66–0.71)Validation = 0.67 (0.65–0.70)1. Number of positive responses to screening test52. Age3. Sex4. Hospitalization in previous 6 months5. ≥5 prescriptions
Mishra6 [34]Mixed effects logistic regressionFull model approachResidents at an Aging-in-Place facility, United States, 2011–2019N/A150 participants, 4495 individual assessmentsPredictors and outcome = routinely collected assessments in EMR every 6 monthsED visit or hospital admission within 6 monthsNR0.72 (0.65–0.79)Geriatric assessments:1. ADL6a2. IADL6b3. Depressive symptoms6c4. Cognition6d5. Mental health6e6. Physical health6e
O’Caoimh [41]RISC (Risk Instrument for Screening in the Community)Iterative process of item generation and reduction using literature searches and focus groups with public health nurses (PHN)Community-dwelling adults ≥65 under follow-up by PHN, Ireland, 2012–2013N/A801Predictors = PHN review and additional GP informationHospitalization = Data from hospital enquiriesAcute admission to an acute hospital within 12 monthsValidation = 142 (17.7%)Validation = 0.61 (0.55–0.66)1. Age2. Gender3. Living arrangement4. Presence and magnitude of concern for PHN across 3 domains:• Mental state• ADL• Medical/physical state5. Ability of caregiver to manage (according to PHN)
Reuben [35]Logistic regressionMedicare beneficiaries aged ≥65, United States, 1988–199225692569 (split sample)10-fold cross-validationPredictors = Interviews, physical examination, and laboratory testsThree models developed =1. Self-reported prior hospitalizations only2. Self-report variables3. Self-report, physical examination, and laboratory variablesOutcome = claims dataHigh utilization (≥11 hospital days in 3 years)Full cohort = 1243 (24.2%)Full cohort (after cross-validation) =1. 0.602. 0.683. 0.69Self-reported predictors:1. Any hospitalization in previous year2. Any hospitalization in year before that3. Male gender4. Fair or poor health5. Not currently working6. Little participation at religious services7. Need help with bathing8. Unable to walk a mile9. Diabetes, sugar in urine, or high blood sugar,10. Taking loop diureticsLaboratory results:11. Serum albumin12. Serum iron
Roos [42]Logistic regressionInsured participants aged ≥65 years, Canada 1970–197315181518 (split sample)Predictors = Three models were compared1. Administrative data only2. Interview data3. Administrative and interview dataOutcome = claims dataHospital admission within 24 monthsNRNRInterview questions:1. Self-rated health2. Reported conditions of arthritis, diabetes, chest3. Reported undergoing ≥1 treatment4. Amount of time spent in hospital in last yearAdministrative data:5. Living with spouse6. Prior hospital utilization in last year7. Prior ambulatory utilization in last year
Shelton [36]CARS (Community Assessment Risk Screen)Logistic regressionMedicare patients with ≥1 specified characteristic and ≥65 years, United States, 1993–19954111054 (external validation)Predictors = telephone interviews, mailed questionnairesOutcome = claims files (hospitalization) and self-report (ED visit)Hospitalization or ED visit in 12 monthsDerivation = 131 (31.9%)Validation = 304 (28.8%)Derivation = 0.74Validation = 0.671. Any of the following conditions: heart disease, diabetes, myocardial infarction, stroke, COPD, cancer2. 5 or more prescription drugs3. ED visit or unplanned hospital admission in past 6 months
Wu [37]Logistic regressionFull model approachMedicare beneficiaries aged ≥65 in longitudinal aging study, United States, 2010–20124457Leave-one-out cross validationPredictors =1. survey based (S)2. claims based (C)3. survey and claims based (S+C)Outcome = claims data1. Any hospital admission within 12 months2. Preventable hospital admission within 12 months1. Any hospital admission = 1046 (21.0%)2. Preventable hospital admission = 245 (4.5%)1. Any hospital admission:• Survey based = 0.67• Claims based = 0.71• Combined = 0.722. Preventable hospital admission:• Survey based = 0.72• Claims based = 0.76• Combined = 0.781. Frailty status (S)72. Number of major ADGs2a (C, S+C)3. Number of geriatric risk factors2c (C, S+C)

ADL: activities of daily living, ADG: Aggregated Diagnostic Group, AMTS: Abbreviated Mental Test Score, C: claims based model; CCI: Charlson Comorbidity Index; ED: emergency department, IADL: instrumental activities of daily living, MMSE: Mini-Mental State Examination, NR: not reported, PHN: public health nurse, S: survey assessment based model; C+S: combined survey and claims based model

1 The Charlson Comorbidity Index incorporates 17 weighted comorbidity conditions. A score of ≥2 is a commonly used cut-point to indicate high comorbidity.

2 An inclusion criterion for age was not specified. Mean age of the sampled population was 76.1 ± 7.3. (a) Major ADGs refers to 8 major aggregated diagnostic groups assigned by the John Hopkins ACG System, which have very high expected resource use. (b) Hospital dominant conditions were based on diagnoses that are associated with markedly higher probability of future hospitalization. (c) The geriatric risk index was based on the presence of 1 or ≥2 of the 10 geriatric risk factors (i.e. falls, walking difficulty, severe issues with bladder control, absence of fecal control, weight loss, malnutrition, vision impairment, dementia/cognitive impairment, presence of decubitus/pressure ulcers, lack of social support).

3 Due to multicollinearity between the ADL and IADL limitation variable, two models were developed. In the model with IADL limitation, proxy response was added as predictor. All other variables were identical.

4 These three variables were separately assessed as number of events in the year before index date and number of events in the year before that.

5 The screening test was a seven item questionnaire answered by the primary care physician and contained information on limitations in ADLs and IADLs, poor vision, poor hearing, recent unintentional weight loss, use of homecare services, and inadequacy of income.

6 One of the study participants was aged 62 at inclusion. The geriatric assessment was composed of (a) the Short Form ADL, RAI MDS 2.0 for ADL, (b) the Lawton IADL scale for IADL, (c) the Geriatric Depression Scale for depression, (d) the Mental State Examination for cognition and (e) the mental component score and physical component score of the Short Form-12, a 12-item Health Survey.

7 Frailty status was categorized as robust, pre-frail and frail, and was based on the five criteria of the Fried frailty phenotype.

Table 2

Prediction model developed using machine learning techniques.

First author + referenceAcronymCompared algorithms1Population + SettingDerivation, nValidation, nData used for final modelOutcomeNumber of outcome events, n (%)AUC (95% CI) of best performing algorithmFeatures in final model
Tarekegn [39]SVMANNRFDTLRGPPatients in primary care aged ≥65 years, Italy, 2016–20171) Urgent hospitalization = 1,095,6132) Preventable hospitalization = 1,095,613N/A10-fold cross-validation procedureFeatures and outcome = data from administrative and health databases in the Piedmontese Longitudinal Study1) urgent hospitalization2) preventable hospitalization2Horizon = 12 monthsDerivation =1) Urgent hospitalization = 38,918 (3.55%)2) Preventable hospitalization = 19,072 (1.74%)Validation = N/A1) Urgent hospitalization = 0.75(SVM)2) Preventable hospitalization = 0.74(ANN, SVM and LR)1) Urgent hospitalization = 34 features2a2) Preventable hospitalization = 33 features2aVariable categories: Sociodemographic, medical history, medication, healthcare utilization, functional status

AUC: area under the curve, CI: confidence interval, DT: decision tree, GP: genetic programming, LR: logistic regression, ML: machine learning, ANN: artificial neural network, RF: random forests; SVM: support vector machine

1 Algorithms used for feature selection and performance measures, unless stated otherwise.

2 A definition of preventable hospitalizations was not reported. (a) Ten most important features (equal for urgent and preventable hospitalizations): age, mental disease, poly prescriptions, diseases of the respiratory system, citizenship, non-urgent visit (white code), arthropathy, diseases of the circulatory system, glaucoma. NB These variables were not further specified.

ADL: activities of daily living, ADG: Aggregated Diagnostic Group, AMTS: Abbreviated Mental Test Score, C: claims based model; CCI: Charlson Comorbidity Index; ED: emergency department, IADL: instrumental activities of daily living, MMSE: Mini-Mental State Examination, NR: not reported, PHN: public health nurse, S: survey assessment based model; C+S: combined survey and claims based model 1 The Charlson Comorbidity Index incorporates 17 weighted comorbidity conditions. A score of ≥2 is a commonly used cut-point to indicate high comorbidity. 2 An inclusion criterion for age was not specified. Mean age of the sampled population was 76.1 ± 7.3. (a) Major ADGs refers to 8 major aggregated diagnostic groups assigned by the John Hopkins ACG System, which have very high expected resource use. (b) Hospital dominant conditions were based on diagnoses that are associated with markedly higher probability of future hospitalization. (c) The geriatric risk index was based on the presence of 1 or ≥2 of the 10 geriatric risk factors (i.e. falls, walking difficulty, severe issues with bladder control, absence of fecal control, weight loss, malnutrition, vision impairment, dementia/cognitive impairment, presence of decubitus/pressure ulcers, lack of social support). 3 Due to multicollinearity between the ADL and IADL limitation variable, two models were developed. In the model with IADL limitation, proxy response was added as predictor. All other variables were identical. 4 These three variables were separately assessed as number of events in the year before index date and number of events in the year before that. 5 The screening test was a seven item questionnaire answered by the primary care physician and contained information on limitations in ADLs and IADLs, poor vision, poor hearing, recent unintentional weight loss, use of homecare services, and inadequacy of income. 6 One of the study participants was aged 62 at inclusion. The geriatric assessment was composed of (a) the Short Form ADL, RAI MDS 2.0 for ADL, (b) the Lawton IADL scale for IADL, (c) the Geriatric Depression Scale for depression, (d) the Mental State Examination for cognition and (e) the mental component score and physical component score of the Short Form-12, a 12-item Health Survey. 7 Frailty status was categorized as robust, pre-frail and frail, and was based on the five criteria of the Fried frailty phenotype. AUC: area under the curve, CI: confidence interval, DT: decision tree, GP: genetic programming, LR: logistic regression, ML: machine learning, ANN: artificial neural network, RF: random forests; SVM: support vector machine 1 Algorithms used for feature selection and performance measures, unless stated otherwise. 2 A definition of preventable hospitalizations was not reported. (a) Ten most important features (equal for urgent and preventable hospitalizations): age, mental disease, poly prescriptions, diseases of the respiratory system, citizenship, non-urgent visit (white code), arthropathy, diseases of the circulatory system, glaucoma. NB These variables were not further specified.

Description of included studies

Of the 19 studies included, the majority were developed in the United States (n = 10) [28-37] and two in Italy [38, 39]. The other studies were developed in the United Kingdom [40], Ireland [41], Canada [42], Sweden [43], Spain [44], Taiwan [45], and South-Korea [46]. Twelve studies included participants aged ≥65 years [29, 33, 35–39, 41, 42, 44–46], the remaining studies used a higher age as inclusion criterion with 81 years [30] as the highest minimum age for inclusion. Total sample sizes ranged from 150 [34] to 1,095,613 [39] participants. Two studies were developed in patients receiving home or community care [34, 41], and one study developed a prediction model in older adults with a vision and/or hearing impairment [29]. Eight studies developed their model using administrative or electronic medical record data [31, 32, 34, 39, 43–46]. Eight studies used survey data to develop their model [28–30, 33, 36, 38, 40, 41], and three models were developed using both [35, 37, 42]. Various outcomes were assessed in the development of the prediction models. Two studies validated their models for more than one outcome (i.e. unplanned hospitalizations and potentially preventable hospitalizations, separately) [37, 39]. Two models predicted a combined endpoint of any hospitalization or ED visit [34, 36]. Fourteen studies assessed unplanned hospitalizations as single endpoint [29–33, 37–45], two studies predicted multiple hospitalizations within a specific time period [28, 35], and three studies presented a model for potentially preventable hospitalizations [37, 39, 46]. Two out of these three studies defined admissions as potentially preventable based on the principal diagnosis on admission [37, 46]. The third study did not report its definition for preventable admissions [39]. The prediction horizon ranged from 4.5 months [30] to 4 years [28]. The majority of studies (n = 12) were developed to predict the outcome within 12 months [29, 31, 32, 36, 37, 39–41, 43–46].

Variables used in prediction models

The number of predictors included in the final model ranged from 3 [36] to 38 [43]. The variables most frequently included in the final models were previous hospital admission (n = 11) [28, 29, 31, 35, 36, 38, 40, 42–44, 46], age (n = 11) [28, 31–33, 37–39, 43–46] and sex or gender(n = 8) [28, 32, 33, 35, 37, 38, 43, 44] (Table 3). Twelve studies included one or more specific diseases in the final model, of which cardiovascular diseases (e.g. coronary artery disease, heart failure, or hypertension) were most frequently included (n = 11) [28–30, 33, 36, 39, 40, 42–45]. The most frequently included cardiovascular predictor was ischemic heart disease (n = 7) [28, 29, 33, 39, 42–44]. Diabetes was included in seven models [28, 30, 33, 35, 42–45]. Other frequently included medical diagnoses were cancer (n = 4) [29, 33, 43, 45] and COPD or respiratory problems (n = 4) [33, 39, 44, 45]. Six studies included a multimorbidity measure, either defined as the Charlson Comorbidity Index or a disease count, in the final model [31, 32, 36, 37, 44, 46]. Living arrangement (mostly defined as living alone) was considered for inclusion in seven models [28, 29, 33, 35, 36, 40, 42], and was retained in one model [42]. This model defined living arrangement as living with a spouse.
Table 3

Variables included in and excluded from the models.

CategoryVariableIncluded in final model, N, (%)Excluded after evaluation, N (%)
Demographics Age11 (73%) [28, 3133, 3739, 4346]4 (27%) [29, 35, 36, 42]
Sex8 (62%) [28, 32, 33, 35, 37, 38, 43, 44]5 (38%) [29, 31, 36, 42, 46]
Education2 (33%) [33, 45]4 (67%) [28, 29, 35, 36]
Race/ethnicity2 (40%) [33, 37]3 (60%) [28, 29, 31]
Income/SES1 (20%) [38]4 (80%) [28, 29, 35, 46]
Residential area3 (100%) [33, 39, 46]0
Marital status1 (33%) [31]2 (67%) [36, 45]
Insurance coverage2 (50%) [33, 46]2 (50%) [29, 31]
Employment1 (100%) [35]0
Health status Self-rated health5 (63%) [28, 29, 35, 40, 42]3 (37%) [28, 30, 36]
Mental health2 (50%) [34, 41]2 (50%) [35, 36]
Physical health2 (67%) [34, 41]1 (33%) [36]
Use of alcohol or tobacco1 (50%) [33]1 (50%) [35]
Medical history Specific medical diagnoses12 (63%) [2830, 33, 35, 36, 39, 40, 4245]7 (37%) [28, 29, 33, 35, 40, 44, 45]
Multimorbidity6 (86%) [31, 32, 36, 37, 44, 46]1 (14%) [35]
Sensory impairment4 (50%) [32, 33, 37, 38]4 (50%) [28, 33, 35, 40]
Cognitive impairment5 (83%) [3234, 37, 40]1 (17%) [28]
Health care utilization Prior hospitalization11 (73%) [28, 29, 31, 35, 36, 38, 40, 4244, 46]4 (27%) [28, 30, 42, 45]
Prior ED visit3(60%) [29, 43, 45]2 (20%) [30, 46]
Prior outpatient visits2 (40%) [28, 43]3 (60%) [28, 30, 42]
Primary care visits1 (100%) [31]0
Continuity of care01 (100%) [46]
Receiving homecare2 (67%) [38, 45]1 (33%) [28]
Previously in LCF03 (100%) [30, 31, 35]
Receiving treatment for specific condition1 (50%) [42]1 (50%) [31]
Laboratory results1 (33%) [35]2 (67%) [31, 35]
Barrier to receiving care01 (100%) [29]
Satisfaction with received health care01 (100%) [29]
Medication Number of prescription medication5 (71%) [36, 38, 39, 44, 46]2 (29%) [30, 40]
Use of a specific medication2 (67%) [35, 39]1 (33%) [35]
Social status Caregiver availability3 (67%) [28, 41]1 (33%) [40]
Lack of social support2 (67%) [32, 37]1 (33%) [35]
Living arrangement1 (14%) [42]6 (86%) [28, 29, 33, 35, 36, 40]
Functional status ADL6 (75%) [29, 3335, 38, 41]2 (25%) [30, 40]
IADL3 (50%) [30, 34, 38]3 (50%) [29, 30, 35]
Urinary or fecal incontinence3 (43%) [32, 33, 37]4 (57%) [28, 30, 35, 40]
History of falls2 (40%) [32, 37]3 (60%) [28, 30, 40]
Mobility6 (86%) [30, 35, 39, 40, 42, 46]1 (14%) [28]
Malnutrition or weight loss3 (100%) [32, 37, 38]0
Other Recent stressful event02 (100%) [30, 40]
Need help to complete survey1 (33%) [33]2 (67%) [30, 33]
Participation at religious events1(100%) [35]0
State of home01 (100%) [42]

ADL: activities of daily living, ED: emergency department, IADL: instrumental activities of daily living, LCF: long-term care facility, SES: socio-economic status. This table is limited to the information provided in the publications.

ADL: activities of daily living, ED: emergency department, IADL: instrumental activities of daily living, LCF: long-term care facility, SES: socio-economic status. This table is limited to the information provided in the publications.

Predictive accuracy of the models

Two studies analyzed predictive performance of the same prediction model for two different outcomes [37, 39]. One study did not report its predictive performance [42]. Eighteen studies reported an AUC, ranging from 0.61 to 0.78 after validation. The models published after 2014 tended to perform better; median AUC was 0.72 (range 0.64–0.78) (n = 9), whereas the median AUC from the models in the previous reviews was 0.67 (range 0.61–0.76) (n = 9). Models developed using survey data had median AUC of 0.67 (range 0.61–0.72) (n = 8), the median AUC of models developed with administrative data was 0.73 (range 0.64–0.78) (n = 8). Studies that used both data sources are not included in this count. The models developed for a specific type of hospitalization (i.e. preventable hospitalization or fall with hospitalization) (n = 3), tended to perform better than the models for all-cause hospitalization (n = 17), with a median AUC of 0.78 (range 0.74–0.78) versus 0.69 (range 0.61–0.76), respectively. The two models that assessed AUCs for both outcomes (i.e. Tarekegn et al. and Wu et al. [37, 39]) were included in calculations of both medians with its corresponding AUC and were thus counted twice.

Methodological quality

Overall, the methodological quality of included studies was low (Table 4). Risk of bias was either high or unclear in all studies, predominantly due to bias or insufficient reporting in the analysis domain. More specifically, the handling of missing data was not reported or performed inappropriately in ten studies [29, 31, 33, 36, 37, 40–42, 44, 45], eight studies selected predictors based on univariable analyses [30, 31, 33, 35, 40, 42, 43, 45], and five studies solely handled a split-sample procedure for internal validation [28, 30, 31, 33, 45]. Whereas almost all studies (except one [42]) reported model performance in terms of discrimination, only five sufficiently evaluated calibration [28–30, 38, 45]. Four studies only reported results of the Hosmer-Lemeshow test as a single calibration measure [31, 35, 40, 44].
Table 4

Methodological quality assessment of included prediction models according the recommendations of the PROBAST.

First authorRisk of biasApplicabilityOverall
ParticipantsPredictorsOutcomeAnalysisEPV1ParticipantsPredictorsOutcomeROBApplicability
Boult---+48---+-
Deardorff---?103+--?+
Freedman---+NI---+-
Inouye---+60---+-
Kan+--?358---+-
Kim---+168---+-
Kurichi---+NI---+-
Lin+--+2003+--++
Lopez-Aguila---+54---+-
Lyon---+44---+-
Marcusson---+87---+-
Mazzaglia---+64---+-
Mishra---?NI+--?+
O’Caoimh---?12---?-
Reuben---+36---+-
Roos---+NI---+-
Shelton---+8---+-
Tarekegn---/?2?129-?-??
Wu---/+3?27---?/+3-

+: high risk of bias/concern for applicability, -: low risk of bias/concern for applicability,?: unclear risk of bias/concern for applicability. EPV: events per variable, ROB: risk of bias, NI: no information (i.e. either number of events or number of candidate predictors was not reported)

1 For studies where multiple outcomes were assessed, only the lowest number of events per variable per study is reported.

2 For the outcome preventable hospitalization, no definition was reported, ROB was therefore evaluated as unclear. For the outcome acute hospital admission, ROB in this domain was low.

3 ROB was low for the outcome any inpatient hospital admission. ROB was high for the outcome preventable hospital admissions, since predictors were included in the outcome definition. Overall ROB was therefore unclear and high, respectively.

+: high risk of bias/concern for applicability, -: low risk of bias/concern for applicability,?: unclear risk of bias/concern for applicability. EPV: events per variable, ROB: risk of bias, NI: no information (i.e. either number of events or number of candidate predictors was not reported) 1 For studies where multiple outcomes were assessed, only the lowest number of events per variable per study is reported. 2 For the outcome preventable hospitalization, no definition was reported, ROB was therefore evaluated as unclear. For the outcome acute hospital admission, ROB in this domain was low. 3 ROB was low for the outcome any inpatient hospital admission. ROB was high for the outcome preventable hospital admissions, since predictors were included in the outcome definition. Overall ROB was therefore unclear and high, respectively. The median EPV was 60 and ranged from 8 [36] to 2003 [45] (n = 15). Two studies reported an EPV <20 [36, 41]. In four studies the EPV could not be computed because data on the number of events or the number of candidate predictors were not reported [30, 33, 34, 42]. The models published after 2014 had a higher EPV (median = 129 (range 27–2003)) than the older models (median = 46 (range 8–64)). Concern for applicability was high in three studies, because the study population or study outcome did not fully match the review question: one study only included older adults with a sensory impairment [29], one study excluded older adults with a hospital admission <6 months prior to the index date [45], and one study evaluated preventable hospital admissions as only outcome [46].

Discussion

This systematic review identified 19 prediction models to predict unplanned hospital admissions in community-dwelling older adults. With our search strategy we built on a review by Wallace et al. on the same topic, however focusing the study population to adults aged 65 years and over. In total we identified 19 prediction models, of which the current review added 10 new prediction models that were not included in the previous reviews. The new models had higher predictive accuracy than the older models. This might be explained by the fact that new models had larger samples of the development cohort and also higher EPVs than the older models. Both are recommended by the TRIPOD guidelines, published in 2015 [16], to improve predictive accuracy and methodological quality. Moreover, the new models used administrative or clinical record data more often for the development of their model. Consistent with Wallace et al., we found that models developed using administrative or clinical record data had higher predictive accuracy than those developed using self-report data. Of the 10 new prediction models, eight used administrative data for development of their model. To potentially improve predictive accuracy, Wallace et al. suggested to consider nonmedical factors (e.g. social support and functional status) [13]. Despite this recommendation, these variables were rarely evaluated for inclusion in the latest studies. We found that predictors most frequently included in the final models were medical diagnoses (specifically heart disease), prior hospitalizations, age, and sex, which is in line with Wallace’s findings. These risk factors seem to have more impact in the prediction of unplanned admissions than nonmedical factors, considering the relatively high beta-coefficients of these variables in most models (data not shown). Also, chronic diseases and health care use variables are probably more readily available in large routine care data, whereas nonmedical factors are rarely assessed in a systematic way. Overall, reporting of methodology and findings was often inappropriate or lacked relevant information, risk of bias was therefore either unclear or high in all models. Moreover, despite the publication of the TRIPOD guidelines in 2015, only one [29] out of seven studies published after 2015 reported their study according to the TRIPOD checklist. The majority of studies showed high risk of bias in the analysis domain. Mainly because of univariable analyses as selection method or inappropriate handling of missing data.

Strengths and limitations

The aging population across the globe and increasing interest in personalized medicine makes this review topical. We added a substantial number of prediction models to the previous systematic reviews on this topic. Furthermore, we conducted a thorough search strategy using a validated search filter and assessed data using tools specifically designed for systematic reviews of prognostic studies. However, there are some limitations. First, care must be taken with directly comparing the prediction models because of heterogeneity in study characteristics (e.g. study populations, and selection of candidate predictors) and study outcomes. Since models perform differently in other populations, comparison of predictive performance can only be performed when these models are validated in the same sample. Further, by limiting our inclusion criteria to participants aged 65 and over, we excluded potential prediction models developed in participants with younger age. For example, the DIVERT scale, a tool to predict emergency department visits, was developed in home care clients aged ≥50 years. Even though reported AUCs are a little over 0.6 after geographical validation, targeted application of the risk score has shown its clinical added value for cardiorespiratory management and reduction of hospitalizations in home care recipients [47]. Last, while in principle CHARMS and PROBAST are relevant for prediction model studies using ML, they predominantly focus on regression-based modelling and some unique aspects of ML methods are not captured [48]. This complicated the critical appraisal of the ML study and therefore risk of bias was unclear. Necessity for guidelines for reporting and critical appraisal of prediction model studies using ML has been addressed and PROBAST-ML (as well as TRIPOD-ML) has been announced [48]. Until then, it is recommended to use TRIPOD, CHARMS and PROBAST as benchmark for the development of prediction model studies rather than none [49].

Implications for future research

Our findings provide a proper basis of prediction models on hospitalizations in older people. Knowing that prediction models often perform worse in new populations, external validation studies are needed to assess generalizability across different countries and healthcare systems. Moreover, models that underperform in external samples should not be discarded and studies should assess the possibility of updating existing models by recalibrating, adjusting weights or considering additional predictors [50, 51]. This way, data of the original development model is not wasted. However, updating of a prediction model is only recommended provided that the initial model was appropriately developed and demonstrated promising accuracy [51]. Most prediction models in this review are poorly reported and all are at either high or unclear risk of bias, which makes updating of the existing models more complicated and we therefore cannot recommend one specific model. Moreover, while recalibration and adjusting weights only affect a model’s calibration, adding (previously missed) important predictors should be considered to improve a model’s discrimination [51]. As mentioned above, nonmedical factors remain under researched in the prediction of hospital admissions in older adults. Taking into account the influence of nonmedical factors on unscheduled secondary care use [52, 53], these variables may contribute to a better discriminative ability of the model. Last, for both development studies and validation studies we advise to fully report all modelling steps and analysis in sufficient detail according to the TRIPOD guidelines [16]. The TRIPOD guidelines have been developed to improve the reporting of studies developing, validating, and updating prognostic models and to maximize transparency and reproducibility. More specifically, for example, predictive performance should not only be evaluated in terms of discrimination, but also in terms of calibration. Regarding calibration, it is recommended to include a calibration plot or table in addition to the p-value of the Hosmer-Lemeshow test. Furthermore, variables or participants with missing data should not simply be omitted, multiple imputation is recommended as the preferred method for handling of missing data to decrease bias [26].

Implications for future practice

Our study found that the models to predict preventable hospitalizations tended to have better predictive ability than models for all-cause hospitalizations. Preventable admissions reflect admissions for conditions that could have been managed with timely and effective treatment by outpatient primary care (e.g. pneumonia, congestive heart failure, and COPD, often also referred to as ambulatory care sensitive conditions (ACSCs)) [54]. Interventions targeted at older adults with ACSCs provide a window of opportunity for prevention of admissions. Possibly even more so if targeted at persons with additional important risk factors (e.g. recent hospitalization, polypharmacy and/or multimorbidity). In consequence, reduction of the incidence of preventable admissions could substantially lower healthcare costs, and improve health outcomes and older adult’s quality of life [11]. There is however limited evidence for effective preventive interventions to reduce preventable admissions in general [54]. High continuity of care with a general practitioner is associated with lower rates of hospital admissions [55]. Furthermore, several targeted interventions have shown to be effective in patients with specific diseases, such as self-management in patients with COPD and heart failure, and telemedicine in patients with heart failure [11]. Focusing on these targeted interventions may have a beneficial impact on the reduction of hospital admissions in community-dwelling older adults [54].

Conclusion

The prediction models developed to predict preventable hospitalizations tended to perform better than models predicting all-cause hospitalizations. Focusing on enhancing primary care management of conditions related to these preventable admissions may have a beneficial effect on health care quality. To improve predictive accuracy of prediction models the use of administrative data sources is recommended as well as incorporation of important variables, i.e. age, prior hospitalization and multimorbidity. The impact of nonmedical factors remains unresearched. Moreover, future researchers are recommended to follow the TRIPOD guidelines for prediction model studies, as methodological quality of reporting and analyses of the included studies was low.

PRISMA checklist.

(PDF) Click here for additional data file.

Full search strategies.

(PDF) Click here for additional data file.

CHARMS and PROBAST forms.

(PDF) Click here for additional data file. 2 Mar 2022
PONE-D-21-38410
Risk prediction models for the prediction of unplanned hospital admissions or emergency department visits in community-dwelling older adults: a systematic review.
PLOS ONE Dear Dr. Klunder, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ACADEMIC EDITOR: We now have 3 reviews available of your manuscript. You will see that the reviewers were quite positive about this research but did raise a number of suggestions to improve the clarity of the manuscript - some related to the structuring of the manuscript and other focused on providing more detail on certain decisions. As well, you will also see that the reviewers raised some concerns about the discussion of machine learning techniques vs regression and are generally looking for a more nuanced take on this issue. Please submit your revised manuscript by Apr 16 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Andrea Gruneir Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A Reviewer #3: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: An interesting systematic review on risk prediction models for hospitalizations among community-dwelling older adults. The review looks to be well-conducted and the conclusions soundly based in the results. I appreciate the focus on the methodological quality of the studies in addition to their performance. I have a few suggestions that I believe well aid in the clarity of their manuscript Abstract 1. Line 25: In the Abstract the inclusion criteria is that models had to be intended to be used in a “primary care setting” whereas in the Methods section it is “general practice or community care”. This may be a jurisdictional difference, but I would not typically consider community care to be part of primary care so do not see these statements as equivalent. Can the authors align the definitions? 2. Line 27: Do the authors mean “quality” assessment? 3. Line 31: I believe that “sex or gender” would be more accurate according to the data in Table 2 Introduction 4. Lines 60-63. I might be misunderstanding this sentence, but it sounds like the authors are saying that regression models at more at risk of overfitting than machine learning models, which is not typically true. Machine learning models are much more complex than regression models. This complexity leads to both a theoretical benefit for predictive performance as well as an increased risk of overfitting. Some of the papers that the authors have cited [13 – for example] discuss this. Methods 5. Line 108. I’m confused about the scope and justification of this exclusion. I can understand wanting to excluding studies done in disease-specific populations. But I am not grasping why studies among patients with cognitive impairments were specifically included when studies done in patients with heart failure, for example, presumably were excluded. Could the authors provide more detail and justification? 6. Line 132: Could the authors briefly list the domains of high heterogeneity in this sentence? Results 7. Line 203: “sex or gender” is likely more accurate Table 3 8. Presentation of the data in an N(%) format would be more informative than listing the reference numbers Discussion 9. Feature/variable selection is a controversial and complex topic and I think the authors could benefit from more nuance in their discussion. For example, backwards selection is clearly superior to univariable screening, but it still comes with its own challenges. The use of any automated selection model (as noted in [14 and 15]) bears risks and p-value based approaches in particular lack justification. Could the authors expand this section, comment on other available methods ,i.e. LASSO, other methods as detailed in https://doi.org/10.1016/j.jclinepi.2015.10.002 and https://doi.org/10.1016/j.ijmedinf.2018.05.006 and comment that some ML methods have feature/variable selection incorporated into their algorithms. Reviewer #2: The authors have presented an updated systematic review in this paper. The study is interesting and the approach is adequately robust. My specific comments are given below. 1. Is there a specific rationale for the chosen time frame for searching literature (2013-2021)? 2. Also, is there a specific reason for restricting the participants to adults > 65 years of age? 3. Time frame ranges from 7 days to 4 years. Was there any discernible temporal decay in the predictive performance across the models over this relatively longer time window? In other words, did those models predicting a shorter time span perform better than those predicting longer time spans? 4. The study has found that models developed to predict preventable hospitalizations had better predictive performance than models predicting hospitalizations in general. I think the authors should elaborate further on the clinical implications of this important finding. 5. Machine learning/deep learning-based models are quite different from traditional statistical models in a number of ways. The inclusion of a large number of variables in ML/DL models is, in fact, not an issue and modelling in a high-dimensional space is permissible with ML/DL. Therefore, using the guidelines (TRIPOD/CHARMS/PROBAST) geared to assessing classic predictive models for ML/DL models may not be ideal. Authors should discuss the implications of this and likely limitations. 6. Authors have presented the different variables included in each model. What predictors were actually found to be important in these predictive models? What predictors were statistically significant in classic predictive models and what variables emerged as important in ML models? For instance, ML uses techniques such as variable importance metrics and Shapley additives to gauge predictor importance. 7. Suggested to include eligibility criteria in a standard PICOTS table. 8. It would be important to describe in detail what additional and novel findings emerged from this SR, compared to the two previous SR on the same domain. 9. Both split-sample validation and cross-validation have their limitations. External validation is a great way to assess the robustness and generalizability of predictive models. How many of these models were externally validated? Reviewer #3: First of all I would like to thank and congratulate the authors on their work. The topic of this systematic review is very interesting and important. The manuscript lacks however, structure and does not always read well. See my suggestions and questions below to improve this work. BACKGROUND Use of “risk” prediction modeling is a confusing and uncommon terminology. Recommend to use solely prediction model. This will probably improve the readability of the manuscript. A very large proportion of the introduction is being used to describe prediction models, big data and machine learning in general. This does not read well, and does not add very much value to the topic of this systematic review. I would recommend to explain more about the “burden” of older patients at the emergency department. For example, how many times are patients admitted to and ED?; What are the reasons that they visit the ED? Are these reasons preventable? This will highlight the importance of this research. Additionally, I would also recommend to focus on the effects of ED admission and hospitalization on the elderly, such as the loss of functionality, risk of delirium during admission, psychological effects etc. Additionally, the authors described that with an effective primary care intervention, healthcare costs will decrease. I suggest to add details about how identification of these elderly can improve the work of physicians on how they can deliver more qualitative and effective healthcare. METHODS My major concern is the following: in the introduction and methods it is explained that previous reviews included studies focusing on ED admission and case-finding instruments. However, inclusion for this study was limited to studies from 2013 onwards, despite focusing on ED admission and unplanned hospitalization. The reason why the authors chose this specific inclusion year is confusing, as the previous performed reviews do not fully cover the research question of this systematic review. Could the authors explain, how and why this decision was made. Inclusion criteria one, two and four seem obvious. However I think inclusion criteria three and five need more explanation. In general a question to authors: why were only validated prediction models included in this study? With the PROBAST tool, the models are also scored on “validation”. I do not see why development studies are not included. In regards to inclusion criteria five: how do prediction models being used at the ED differ from the ones being used at a primary care facility? Textual comments: Methods section reads cloudy and could be more straightforward. For example: [1] Since these systematic reviews identified the same risk prediction models, we decided to limit publication dates from August 2013 through January 2021, which has some overlap with the searches of these reviews. To give a complete overview, we will also include the studies found in the previous reviews. The references of the identified articles were searched for relevant publications. I would suggest to rephrase to: [1] To provide a complete overview of available prediction models our search was restricted to August 2013 through January 2021. The models described in the previous reviews were also included in this systematic review. Textual comments: [2] After extraction of data, the Prediction model Risk of Bias Assessment Tool (PROBAST; see Appendix B) was used to assess risk of bias and applicability of the predictive models. Concern for applicability addresses whether the primary study matches the review question. I would suggest to rephrase to: [2] The Prediction model Risk of Bias Assessment Tool was used to assess risk of bias and applicability, of which the latter addresses whether the primary study matches the review question. I would suggest to change the structure of the methods section and shorten in. Combine sections search strategy, study selection and data extraction. Make a new subheading with model performance including de explanation about AUC and EPV and lastly discuss the PROBAST tool. The PROBAST tool is explained very extensively. I would recommend to remove details to supplements or just refer to original PROBAST article. Also describe that regression models and machine learning models will be described separately. RESULTS A question for authors: Did all of the included study focus on developing only 1 prediction model? Because in these kind of studies sometimes multiple models are developed/ validated and compared to each other. Is 22 studies equivalent to 22 unique prediction models? Textual comments Same as the methods. Results can be pointed out more straightforward. See examples below. Line 162/168: A flow diagram of the search strategy and selection process is presented in Figure 1, can be removed. Data extracted from the studies can be found in Table 1 and Table 2. Suggest to change it to: The literature searches yielded a total of 16,098 citations (Figure 1.). Tables and figures do not a notification, referring is the standard. Line 164. Additionally, twenty-three articles were identified through other sources. What are these other sources? This was not mentioned in the methods. Line 165: In addition to 10 studies included in the previously published systematic reviews, 12 new studies met all inclusion criteria, which makes a total of 22 unique risk prediction models. Rephrase: Full texts were retrieved for 170 studies of which 12 met all inclusion criteria. Additionally, a total of 10 studies were included from the previously published systematic reviews. I would suggest to refer to “prediction model” instead of “study” in the results sections. For example line 171: Thirteen studies included participants aged ≥65 172 years[29, 33, 34, 36-40, 44, 46-49], the remaining studies used a higher age as inclusion criterion with. Rephrase to: Thirteen prediction models included…….. When describing results, try to hold on to the structure in the methods. The EPV can be described in the “predictive accuracy” section. Avoid using question marks in tables and figures. I would suggest to use NA or a color scheme, for example, high risk= red, low risk= green, unclear= purple. DISCUSSION I do not understand why the difference between machine learning and logistic regression models is discussed prominently in this article. In order to say whether one technique is superior to the other, you should validate both models in the identical population. In line 317 the authors state the machine learning techniques are not superior and in in line 328 the authors state that a fair comparison is not possible. Please be consequent in conclusions. The discussion includes a lot of repetition of the results. Conclusions is solely based on the development of more prediction models. In the introduction the authors describe that the eventual goal is to develop a care management program to avoid these admission. The authors should highlight, how they could use these models to develop such a program. For example; are the variables in these model, standard measurements in a primary care facility? If the conclusion is only developing more models, the authors should describe how to accomplish this. Which data source to use, which variables should be included, which modeling technique etc. Textual comments: Line 293: Twelve risk models were added to the existing evidence. This does not read well. Suggest to remove this sentence. Line 293-295: The recommendation of using nonmedical factors is never mentioned in the manuscript. This conclusion comes a bit out of the blue. I would recommend to make a more general conclusion, on the results that the authors did find (e.g. quality of models, performance of models etc.). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. Submitted filename: Peer review.docx Click here for additional data file. 29 May 2022 Amsterdam, May 1st 2022 Dear editor, We would like to thank you and the reviewers for thoroughly reviewing our manuscript. We have rigorously revised our manuscript and believe its quality has improved. We have addressed each comment point by point below. We have marked important changes in the revised manuscript with track changes and have referred to the page and line numbers in the commentary below. Reviewer #1: An interesting systematic review on risk prediction models for hospitalizations among community-dwelling older adults. The review looks to be well-conducted and the conclusions soundly based in the results. I appreciate the focus on the methodological quality of the studies in addition to their performance. I have a few suggestions that I believe well aid in the clarity of their manuscript Abstract 1. Line 25: In the Abstract the inclusion criteria is that models had to be intended to be used in a “primary care setting” whereas in the Methods section it is “general practice or community care”. This may be a jurisdictional difference, but I would not typically consider community care to be part of primary care so do not see these statements as equivalent. Can the authors align the definitions? �  We agree these terms may be confusing and we thank the reviewer for highlighting this contradiction. Primary care focuses on physical, mental and social health issues, it comprises care mainly performed in general practice and home care. Community care addresses a wider aspect of wellbeing and also focuses on social problems people may experience, such as housing problems. The aim of this review is to find risk prediction models that can be used by either general practitioners or home care professionals, therefore primary care is the most suitable definition. We have changed the definition in both abstract and methods accordingly. (page 2, line 24; page 4, line 104) 2. Line 27: Do the authors mean “quality” assessment? �  We do indeed. We’ve changed this. (page 2, line 26) 3. Line 31: I believe that “sex or gender” would be more accurate according to the data in Table 2 �  We assume all studies refer to the biological characteristics of males and females, which means sex would be the appropriate term. However some included studies use the term gender and do not describe their definition, therefore we changed ‘gender’ into ‘sex or gender’ according to the reviewer’s suggestion. (p2, line 29) Introduction 4. Lines 60-63. I might be misunderstanding this sentence, but it sounds like the authors are saying that regression models at more at risk of overfitting than machine learning models, which is not typically true. Machine learning models are much more complex than regression models. This complexity leads to both a theoretical benefit for predictive performance as well as an increased risk of overfitting. Some of the papers that the authors have cited [13 – for example] discuss this. �  We thank the reviewer for their comment. We could indeed write a whole article on the benefits and disadvantages regression and ML models. In light of the reviewer’s comment and the exclusion of some studies after this peer review, we have decided put less emphasis on the differences between regression and ML in our review, and we have therefore removed this paragraph from our introduction. Methods 5. Line 108. I’m confused about the scope and justification of this exclusion. I can understand wanting to excluding studies done in disease-specific populations. But I am not grasping why studies among patients with cognitive impairments were specifically included when studies done in patients with heart failure, for example, presumably were excluded. Could the authors provide more detail and justification? �  We agree with the reviewer that the argument to exclude prediction models developed in specific populations except for community-dwelling older adults with cognitive impairments is disputable. We have therefore adjusted this criterion in our methods (page 5, lines 111-113) and excluded the two corresponding studies (i.e. Tsang et al.[1] and Maust et al.[2]) from this review. 6. Line 132: Could the authors briefly list the domains of high heterogeneity in this sentence? �  This sentence refers to the impossibility to perform a meta-analysis due to high heterogeneity among the included studies. Our study describes prediction model development studies, these are developed using different statistical methodologies (i.e. different regression analysis methods and ML). A meta-analysis summarizes the estimates of model discrimination and calibration, however due to the wide variation in, among others, outcomes (i.e. (preventable) hospital admissions or both) and prediction horizons (days to years) a quantified average performance in terms of discrimination or calibration would be uninterpretable. Results 7. Line 203: “sex or gender” is likely more accurate �  We have changed this according to their suggestion. (page 8, line 178) Table 3 8. Presentation of the data in an N(%) format would be more informative than listing the reference numbers �  We thank the reviewer for their suggestion. We agree with the reviewer that presentation of percentages in this table is of added value, and we have therefore included these to Table 3 (page 17). Discussion 9. Feature/variable selection is a controversial and complex topic and I think the authors could benefit from more nuance in their discussion. For example, backwards selection is clearly superior to univariable screening, but it still comes with its own challenges. The use of any automated selection model (as noted in [14 and 15]) bears risks and p-value based approaches in particular lack justification. Could the authors expand this section, comment on other available methods ,i.e. LASSO, other methods as detailed in https://doi.org/10.1016/j.jclinepi.2015.10.002 and https://doi.org/10.1016/j.ijmedinf.2018.05.006 and comment that some ML methods have feature/variable selection incorporated into their algorithms. �  We agree with the reviewer that this section is somewhat short-sighted and we have nuanced this section (page 21, lines 337-341). As stated by the reviewer, variable selection is complex and controversial and many methods for variable selection exist. However, for this review we strictly followed the recommendations of the TRIPOD.[3] The TRIPOD is currently considered as the state-of-the-art reporting guideline for prediction model studies and systematic reviews on this topic.[4, 5] According to the TRIPOD, backward elimination is generally preferred if automated predictor selection procedures are used. While some of TRIPOD’s recommendations may offer room for in-depth discussion about the different predictor selection methods, we believe that this is beyond the scope of this paper, especially considering the exclusion of 2/3 ML models after revision. If the editor would like us to elaborate on this issue further, we would like to know and we will gladly accommodate their request. Reviewer #2: The authors have presented an updated systematic review in this paper. The study is interesting and the approach is adequately robust. My specific comments are given below. 1. Is there a specific rationale for the chosen time frame for searching literature (2013-2021)? �  The aim of this review was to update the systematic review of Wallace et al. and in addition, focus on prediction models in adults aged 65 and over. Wallace et al. have performed a thorough literature search with identical inclusion criteria as our study (except for the age criterion). Since Wallace’s last updated search was in February 2014 we decided to overlap our search with 6 months, in case any records were added retrospectively (e.g. to correct an error in indexing) and were not detected by Wallace’s search. 2. Also, is there a specific reason for restricting the participants to adults > 65 years of age? �  Older adults have greater vulnerability to acute stress than younger individuals due to age-related diminution of physiologic reserves. Moreover, older adults tend to have more comorbid illnesses and disability. Older adults are more at risk for hospitalization and require more support after discharge than adults in middle age (45 to 64 years).[6] Prevention of hospital admissions in the older age group seems therefore more important on a community-level. There is however no clear age that defines an older adult. We have chosen the most conventional definition of older adults: people aged 65 and over.[7] We have revised our introduction, putting more focus on the importance of identifying older adults at risk for hospitalizations. 3. Time frame ranges from 7 days to 4 years. Was there any discernible temporal decay in the predictive performance across the models over this relatively longer time window? In other words, did those models predicting a shorter time span perform better than those predicting longer time spans? �  Most studies handled a prediction horizon of 12 months (n=12, 63%). The predictive performance of these models, excluding the ones that predicted preventable hospitalizations or fall with hospitalization, ranged between AUC 0.61 – 0.76 (median AUC = 0.70). Two models were developed to predict a shorter time span, i.e. 6 months (AUC 0.72), and 4.5 months (AUC 0.63). So there was no remarkable superiority of the prediction models with shorter prediction horizon in terms of predictive performance. On the other hand, four studies handled a prediction horizon of more than 12 months (i.e. 15 months to 4 years). These models showed worse predictive ability (median AUC = 0.67, range 0.61 – 0.69) than the models predicting a time span of 12 months. This suggests predictions over a time span of more than 12 months become less accurate. In addition, it is questionable whether predictions of hospital admissions within an interval of multiple years are of clinical added value to clinicians. However, their low accuracy could also be due to the fact that these studies used survey data, whereas models using administrative data tended to perform better. We did therefore not incorporate this finding in the description of our results. 4. The study has found that models developed to predict preventable hospitalizations had better predictive performance than models predicting hospitalizations in general. I think the authors should elaborate further on the clinical implications of this important finding. �  We thank the reviewer for their suggestion and have elaborated on this finding and its clinical implications (page 21-22, lines 353-370) 5. Machine learning/deep learning-based models are quite different from traditional statistical models in a number of ways. The inclusion of a large number of variables in ML/DL models is, in fact, not an issue and modelling in a high-dimensional space is permissible with ML/DL. Therefore, using the guidelines (TRIPOD/CHARMS/PROBAST) geared to assessing classic predictive models for ML/DL models may not be ideal. Authors should discuss the implications of this and likely limitations. �  On page 20, in line 321 and further we discuss the fact that TRIPOD, CHARMS and PROBAST are originally designed for all types of prediction modelling studies, however their focus is indeed on regression-based prediction models. Nonetheless, all TRIPOD items are applicable for ML models. For PROBAST however, two signaling questions might be less relevant (i.e. selection of predictors based on univariable analysis and reporting of weighted estimates in the final model) and more signaling questions, e.g. related to data generation and feature selection, might be necessary. Hence, risk of bias for the ML model in our review was signed as unclear. ML versions of these checklists are under development, until then it is recommended to use TRIPOD, CHARMS and PROBAST as benchmark rather than none. We have added the latter in the manuscript (see underlined sentence below): Necessity for guidelines for reporting and critical appraisal of prediction model studies using ML has been addressed and PROBAST-ML (as well as TRIPOD-ML) has been announced.[8] Until then, it is recommended to use TRIPOD, CHARMS and PROBAST as benchmark for the development of prediction model studies rather than none.[9] 6. Authors have presented the different variables included in each model. What predictors were actually found to be important in these predictive models? What predictors were statistically significant in classic predictive models and what variables emerged as important in ML models? For instance, ML uses techniques such as variable importance metrics and Shapley additives to gauge predictor importance. �  Thanks to the reviewer for their suggestion. We have presented all variables that were statistically significant and thus included in the final models in Table 3. Because of other comments on the difference between classic regression models and ML models, we decided to put less emphasis on the differences between these models. To answer the first question; because every study handled predictors differently (e.g. categorical or continuous analysis of the variable age) and used different numbers of predictors and different predictor selection methods, no quantified conclusions can be drawn on which predictors were most important. In general, previous admissions, high age, multimorbidity, polypharmacy and heart disease were most frequently included in the final models with in most cases high beta-coefficients. We added this to our conclusions. (page 19, line 278-282; page 21, line 359-361) 7. Suggested to include eligibility criteria in a standard PICOTS table. �  We have adapted the inclusion criteria in the manuscript according to the PICOTS format as suggested by Debray et al.[4] (page 4, line 95-104) 8. It would be important to describe in detail what additional and novel findings emerged from this SR, compared to the two previous SR on the same domain. �  We thank the reviewer for their suggestion. We have now described our results in the discussion in light of the findings by the previous reviews. (page 19, lines 276-297) 9. Both split-sample validation and cross-validation have their limitations. External validation is a great way to assess the robustness and generalizability of predictive models. How many of these models were externally validated? �  The models that were externally validated within the same study are reported in Table 1 (n=3, i.e. Marcusson, Mazzaglia, and Shelton). Unfortunately, very few models were externally validated by other researchers. We have not incorporated these in our studies since our primary aim was to summarize predictive models that have been developed to predict unplanned hospital admissions to this date. Reviewer #3: First of all I would like to thank and congratulate the authors on their work. The topic of this systematic review is very interesting and important. The manuscript lacks however, structure and does not always read well. See my suggestions and questions below to improve this work. BACKGROUND Use of “risk” prediction modeling is a confusing and uncommon terminology. Recommend to use solely prediction model. This will probably improve the readability of the manuscript. �  We thank the reviewer for their suggestion and we have changed this accordingly in the manuscript. A very large proportion of the introduction is being used to describe prediction models, big data and machine learning in general. This does not read well, and does not add very much value to the topic of this systematic review. I would recommend to explain more about the “burden” of older patients at the emergency department. For example, how many times are patients admitted to and ED?; What are the reasons that they visit the ED? Are these reasons preventable? This will highlight the importance of this research. Additionally, I would also recommend to focus on the effects of ED admission and hospitalization on the elderly, such as the loss of functionality, risk of delirium during admission, psychological effects etc. Additionally, the authors described that with an effective primary care intervention, healthcare costs will decrease. I suggest to add details about how identification of these elderly can improve the work of physicians on how they can deliver more qualitative and effective healthcare. �  We thank the reviewer for their suggestion. We have revised the introduction according to their suggestion by omitting a large part of the paragraph on machine learning and describing in more detail about the relevance of the topic of our review. (page 3, lines 40-55) METHODS My major concern is the following: in the introduction and methods it is explained that previous reviews included studies focusing on ED admission and case-finding instruments. However, inclusion for this study was limited to studies from 2013 onwards, despite focusing on ED admission and unplanned hospitalization. The reason why the authors chose this specific inclusion year is confusing, as the previous performed reviews do not fully cover the research question of this systematic review. Could the authors explain, how and why this decision was made. �  We understand the reviewer’s concern. With this review we build on the review of Wallace et al. who performed a thorough review in 2014 (20,666 records), for this review our focus was on older adults because of reasons (mentioned in the introduction). Wallace et al. included risk prediction models for hospital admissions or combined endpoints such as hospital admission or ED visits, but did not include prediction models predicting ED visits as single outcome. We agree that this is a gap in our search strategy. We therefore amended our inclusion criterion to hospital admissions only or a combined endpoint of hospital admissions and ED visits. (page 4, line 100-103) This way our inclusion criteria are identical to Wallace et al., except for the restriction to the older population. In consequence, the modification of this inclusion criterion led to the exclusion of one study (i.e. Veyron et al.[10]) in the original version of this review. Inclusion criteria one, two and four seem obvious. However I think inclusion criteria three and five need more explanation. In general a question to authors: why were only validated prediction models included in this study? With the PROBAST tool, the models are also scored on “validation”. I do not see why development studies are not included. �  We thank the reviewer for their comment. Internal validation is considered as a basic procedure in prediction model development studies (in general, but especially for studies with small sample size and/or low EPV). According to the TRIPOD, development studies are defined as development of a prediction model without validation in other participant data, but with inclusion of some form of resampling technique (in other words; including internal validation). Development studies without any form of validation are at high risk of overfitting and thus, according to PROBAST, in principle at high risk of bias. To describe studies that might be useful in daily practice, we only included studies in which overfitting was already accounted for through the execution of any internal validation procedure. In regards to inclusion criteria five: how do prediction models being used at the ED differ from the ones being used at a primary care facility? �  Risk assessment does differ between these settings. Patients already admitted to the ED have higher a priori probability to be admitted to hospital than patients being at home, when risk assessment is performed. Therefore, predictive performance of prediction models in these two settings cannot be compared. Consequently, other variables are selected for inclusion in the models. For instance, the APOP screener [11] includes a variable whether the patient arrived by ambulance. This question can obviously not be answered when this model is used in a primary care setting. Textual comments: Methods section reads cloudy and could be more straightforward. For example: [1] Since these systematic reviews identified the same risk prediction models, we decided to limit publication dates from August 2013 through January 2021, which has some overlap with the searches of these reviews. To give a complete overview, we will also include the studies found in the previous reviews. The references of the identified articles were searched for relevant publications. I would suggest to rephrase to: [1] To provide a complete overview of available prediction models our search was restricted to August 2013 through January 2021. The models described in the previous reviews were also included in this systematic review. �  We thank the reviewer for their suggestion, we have changed this section accordingly. (page 4, lines 88-91) Textual comments: [2] After extraction of data, the Prediction model Risk of Bias Assessment Tool (PROBAST; see Appendix B) was used to assess risk of bias and applicability of the predictive models. Concern for applicability addresses whether the primary study matches the review question. I would suggest to rephrase to: [2] The Prediction model Risk of Bias Assessment Tool was used to assess risk of bias and applicability, of which the latter addresses whether the primary study matches the review question. �  We have changed the sentence accordingly to the reviewer’s suggestion. (page 5, lines 135-137) I would suggest to change the structure of the methods section and shorten in. Combine sections search strategy, study selection and data extraction. Make a new subheading with model performance including de explanation about AUC and EPV and lastly discuss the PROBAST tool. The PROBAST tool is explained very extensively. I would recommend to remove details to supplements or just refer to original PROBAST article. Also describe that regression models and machine learning models will be described separately. �  We thank the reviewer for their suggestion. We have shortened the methods section and removed the elaboration on the PROBAST and referred to the original PROBAST article (page 5, lines 135-139). We have also added a sentence about the separate description of regression models and ML models (page 5, lines 128-129). RESULTS A question for authors: Did all of the included study focus on developing only 1 prediction model? Because in these kind of studies sometimes multiple models are developed/ validated and compared to each other. Is 22 studies equivalent to 22 unique prediction models? �  The majority of studies developed one prediction model, but some indeed presented more models. We presented data of all reported models in Tables 1 and 2. In general we counted one model per study, with the only exception for the comparison of predictive performance between all-cause hospitalizations and preventable hospitalizations. We have added a sentence in the results section to clarify this. (page 8, lines 191-195) We have amended the use of the words study and model, when necessary. The way we handled the different presentation of models is described in detail below: • In case multiple validation procedures were performed (i.e. Lyon and Marcusson) we only reported the highest AUC in the description of our results. In Table 1 all AUCs are reported. • Three studies (i.e. Kan, Reuben, and Wu) used (and combined) multiple data sources to develop multiple models (e.g. survey data and electronic record data). For clarity reasons, we evaluated and discussed the studies as one model, because study characteristics and variables in the final model were identical. For the description of predictive accuracies we only counted the model with the highest AUC. All AUCs are reported in Table 1. • Three studies (i.e. Mishra, Tarekegn, and Wu) assessed multiple outcomes (e.g. all-cause hospitalization and preventable hospitalization) and presented the AUC per outcome. We evaluated and discussed the studies as one model, because study characteristics, methodology and the variables in the final model were identical. However, for the comparison of the predictive accuracy of preventable vs all-cause admissions, we counted these models separately. In other counts we only included the reported AUC for all-cause admission. • The study of Kurichi et al. presented two different models because of collinearity between the ADL and IADL variable. Predictive performance of the models was equal (AUC = 0.67). The variables included in the final model were equal as well, with the minor difference that the IADL model had an extra variable (i.e. proxy responded). Because of these minor differences, we assessed these two models as one. Textual comments Same as the methods. Results can be pointed out more straightforward. See examples below. Line 162/168: A flow diagram of the search strategy and selection process is presented in Figure 1, can be removed. Data extracted from the studies can be found in Table 1 and Table 2. Suggest to change it to: The literature searches yielded a total of 16,098 citations (Figure 1.). Tables and figures do not a notification, referring is the standard. �  We thank the reviewer for their suggestion and have amended accordingly. (page 7, lines 148, 151-152, Line 164. Additionally, twenty-three articles were identified through other sources. What are these other sources? This was not mentioned in the methods. �  Other sources was reference checking, this is mentioned in the methods section and we have now clarified this in the referred line. (page 7, lines 149-150) Line 165: In addition to 10 studies included in the previously published systematic reviews, 12 new studies met all inclusion criteria, which makes a total of 22 unique risk prediction models. Rephrase: Full texts were retrieved for 170 studies of which 12 met all inclusion criteria. Additionally, a total of 10 studies were included from the previously published systematic reviews. �  We thank the reviewer for their suggestion and we have rephrased accordingly. (page 7, lines 150-152) I would suggest to refer to “prediction model” instead of “study” in the results sections. For example line 171: Thirteen studies included participants aged ≥65 172 years[29, 33, 34, 36-40, 44, 46-49], the remaining studies used a higher age as inclusion criterion with. Rephrase to: Thirteen prediction models included…….. �  We thank the reviewer for their suggestion. However, since some studies developed multiple models with the same data source as we pointed out earlier, we believe studies would be more comprehensible. We did check whether there is consistency in the use of ‘models’ and ‘studies’ and adjusted when necessary. When describing results, try to hold on to the structure in the methods. The EPV can be described in the “predictive accuracy” section. �  The EPV is not a measure to assess performance of the model, but is rather used as a sample size criterion to minimize overfitting of a prediction model. Therefore, it is better gathered under the methodological quality section than the predictive accuracy section. Avoid using question marks in tables and figures. I would suggest to use NA or a color scheme, for example, high risk= red, low risk= green, unclear= purple. �  We thank the reviewer for their suggestion. We however presented the methodological quality assessment according to the suggested tabular presentation of the PROBAST study group, which includes the use of question marks. (see Table 12, Moons et al. [12]) DISCUSSION I do not understand why the difference between machine learning and logistic regression models is discussed prominently in this article. In order to say whether one technique is superior to the other, you should validate both models in the identical population. In line 317 the authors state the machine learning techniques are not superior and in in line 328 the authors state that a fair comparison is not possible. Please be consequent in conclusions. �  We thank the reviewer for their comment. We agree the discussion about the differences between machine learning and logistic regression models is put quite superficially, whereas it is a controversial and complicated topic. We have decided to omit most part of this discussion and put more focus on other results of this review. The discussion includes a lot of repetition of the results. Conclusions is solely based on the development of more prediction models. In the introduction the authors describe that the eventual goal is to develop a care management program to avoid these admission. The authors should highlight, how they could use these models to develop such a program. For example; are the variables in these model, standard measurements in a primary care facility? If the conclusion is only developing more models, the authors should describe how to accomplish this. Which data source to use, which variables should be included, which modeling technique etc. �  We thank the reviewer for their suggestion. We have amended the discussion rigorously in light of the comments of the reviewers. We presented suggestions for further improvement of predictive performance and methodological quality of prediction model studies (page 19, lines 295-298; page 20-21, lines 330-352) . Furthermore, we reported clinical implications to the finding that preventable admissions tended to have better predictive performance. (page 21-22, line 354-371) Textual comments: Line 293: Twelve risk models were added to the existing evidence. This does not read well. Suggest to remove this sentence. �  We thank the reviewer for their comment and have removed the sentence. Line 293-295: The recommendation of using nonmedical factors is never mentioned in the manuscript. This conclusion comes a bit out of the blue. I would recommend to make a more general conclusion, on the results that the authors did find (e.g. quality of models, performance of models etc.). �  We thank the reviewer for their comment. As mentioned before, we built on the systematic review performed by Wallace et al. One of the recommendations in this review was to consider nonmedical factors for improvement of predictive accuracy. We have made this conclusion more clear in the manuscript. (page 19, lines 277 and further) References: 1. Tsang G, Zhou SM, Xie X. Modeling Large Sparse Data for Feature Selection: Hospital Admission Predictions of the Dementia Patients Using Primary Care Electronic Health Records. IEEE J Transl Eng Health Med. 2021;9:3000113. PubMed PMID: rayyan-128526376. 2. Maust DT, Kim HM, Chiang C, Langa KM, Kales HC. Predicting Risk of Potentially Preventable Hospitalization in Older Adults with Dementia. Journal of the American Geriatrics Society. 2019;67(10):2077-84. PubMed PMID: rayyan-128520734. 3. Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Annals of internal medicine. 2015;162(1):W1-73. Epub 2015/01/07. doi: 10.7326/m14-0698. PubMed PMID: 25560730. 4. Debray TPA, Damen JAAG, Snell KIE, Ensor J, Hooft L, Reitsma JB, et al. A guide to systematic review and meta-analysis of prediction model performance. BMJ. 2017;356:i6460. doi: 10.1136/bmj.i6460. 5. Group CPM. Cochrane Systematic Review of Prognosis Studies [cited 2022 April 23]. Available from: https://methods.cochrane.org/prognosis/tools. 6. Tian W. An All-Payer View of Hospital Discharge to Postacute Care, 2013: Statistical Brief #205. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006. 7. Kowal P, Dowd J. Definition of an older person. Proposed working definition of an older person in Africa for the MDS Project2001. 8. Andaur Navarro CL, Damen J, Takada T, Nijman SWJ, Dhiman P, Ma J, et al. Protocol for a systematic review on the methodological and reporting quality of prediction model studies using machine learning techniques. BMJ open. 2020;10(11):e038832. Epub 2020/11/13. doi: 10.1136/bmjopen-2020-038832. PubMed PMID: 33177137; PubMed Central PMCID: PMCPMC7661369. 9. Andaur Navarro CL, Damen JAA, Takada T, Nijman SWJ, Dhiman P, Ma J, et al. Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review. BMJ. 2021;375:n2281. doi: 10.1136/bmj.n2281. 10. Veyron JH, Friocourt P, Jeanjean O, Luquel L, Bonifas N, Denis F, et al. Home care aides' observations and machine learning algorithms for the prediction of visits to emergency departments by older community-dwelling individuals receiving home care assistance: A proof of concept study. PloS one. 2019;14(8):e0220002. PubMed PMID: rayyan-128526748. 11. de Gelder J, Lucke JA, de Groot B, Fogteloo AJ, Anten S, Mesri K, et al. Predicting adverse health outcomes in older emergency department patients: the APOP study. Neth J Med. 2016;74(8):342-52. Epub 2016/10/21. PubMed PMID: 27762216. 12. Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration. Annals of internal medicine. 2019;170(1):W1-w33. Epub 2019/01/01. doi: 10.7326/m18-1377. PubMed PMID: 30596876. Submitted filename: Response to Reviewers.docx Click here for additional data file. 18 Jul 2022
PONE-D-21-38410R1
Prediction models for the prediction of unplanned hospital admissions in community-dwelling older adults: a systematic review.
PLOS ONE Dear Dr. Klunder, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 01 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Dong Keon Yon, MD, FACAAI Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please address excellent comments of the reviewers. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #3: I would like to thank the authors for the revised manuscript. The manuscript has significantly improved and is well structured. The introduction contains all relevant information and emphasizes the relevance of this manuscript. However, I still have minor (profoundly textual comments) that can further improve this paper. Line 193-196 Very long and hard to follow sentence. Suggest to rephrase. Line 216 “additionally one study assessed fall with hospitalizations as outcome”. As mentioned in the exclusion criteria, models developed for specific disease groups were excluded. I would suggest to remove this sentence in order the avoid confusion as the model also looked at ED visit and hospital admission. Line 276-277 Replace “and” by “an” line 281-284 suggest to rephrase sentence. Line 338-339 Instead of “narrowing” I would suggest the term “focusing”. Discussion Line 343-344 Suggest to remove the result of AUC>0.8 for fall related hospital admission as suggested earlier. This model performance is namely for fall related hospitalizations. The start of your discussion includes a lot of comparison with Wallace et al. I would suggest to narrow this part and only highlight the most important difference with an explanation. For exammple, in your results and discussion you mention that the predictive accuracy of the current models has significantly improved compared to the models in Wallace et al. Is there any explanation to this? You also mention the further implications for future research. Should we indeed develop more models? And what about the nonmedical factors mentioned by Wallace at al. Could the authors maybe elaborate more on this topic in their discussion. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
1 Sep 2022 Reviewer #1: (No Response) Reviewer #3: I would like to thank the authors for the revised manuscript. The manuscript has significantly improved and is well structured. The introduction contains all relevant information and emphasizes the relevance of this manuscript. However, I still have minor (profoundly textual comments) that can further improve this paper. Line 193-196 Very long and hard to follow sentence. Suggest to rephrase. • We assume the reviewer refers to the following sentence: “For calculations of the median predictive performance we only included the AUC for the outcome all-cause admission, except for the calculation of the median predictive performance per outcome (i.e. preventable and all-cause hospitalization), then AUCs for both outcomes were included.” We agree this sentence causes confusion and have rephrased it: “The models developed for a specific type of hospitalization (i.e. preventable hospitalization or fall with hospitalization) (n=3), tended to perform better than the models for all-cause hospitalization (n=17), with a median AUC of 0.78 (range 0.74-0.78) versus 0.69 (range 0.61 - 0.76), respectively. The two models that assessed AUCs for both outcomes (i.e. Tarekegn et al. and Wu et al.[37, 39]) were included in calculations of both medians with its corresponding AUC and were thus counted twice.” Line 216 “additionally one study assessed fall with hospitalizations as outcome”. As mentioned in the exclusion criteria, models developed for specific disease groups were excluded. I would suggest to remove this sentence in order the avoid confusion as the model also looked at ED visit and hospital admission. • Thank you for your comment. We have removed any reference to the fall-related hospital admissions outcome of this model from the rest of the manuscript, as it is indeed an exclusion criterion mentioned in the methods section. Line 276-277 Replace “and” by “an” • Thank you for noticing the typo. line 281-284 suggest to rephrase sentence. • We have rephrased the sentence accordingly: “Concern for applicability was high in three studies, because the study population or study outcome did not fully match the review question: one study only included older adults with a sensory impairment[29], one study excluded older adults with a hospital admission <6 months prior to the index date[45], and one study evaluated preventable hospital admissions as only outcome[46].” Line 338-339 Instead of “narrowing” I would suggest the term “focusing”. • Thank you, we have followed your suggestion. Discussion Line 343-344 Suggest to remove the result of AUC>0.8 for fall related hospital admission as suggested earlier. This model performance is namely for fall related hospitalizations. • We have removed this sentence in the discussion. The start of your discussion includes a lot of comparison with Wallace et al. I would suggest to narrow this part and only highlight the most important difference with an explanation. For example, in your results and discussion you mention that the predictive accuracy of the current models has significantly improved compared to the models in Wallace et al. Is there any explanation to this? • Thank you for your suggestion. We have narrowed this paragraph and included a possible explanation to the increased predictive accuracy in the newer models. “The new models had higher predictive accuracy than the older models. This might be explained by the fact that new models had larger sample sizes of the development cohort and also higher EPVs. Both are recommended by the TRIPOD, published in 2015 [16], to improve predictive accuracy and methodological quality. Moreover, the new models used administrative or clinical record data more often for the development of their model. Consistent with Wallace et al., we found that models developed using administrative or clinical record data had higher predictive accuracy than those developed using self-report data. Of the 10 new prediction models, eight used administrative data for development of their model.” You also mention the further implications for future research. Should we indeed develop more models? And what about the nonmedical factors mentioned by Wallace at al. Could the authors maybe elaborate more on this topic in their discussion. • Thank you. We have followed your suggestions and have rephrased the implications for future research paragraph. We put more emphasis on external validation and updating prediction models instead of developing new prediction models. Regarding updating of the models, we suggested the addition of nonmedical factors may contribute to an improved accuracy of the model. (Manuscript, pages 19-20, lines 320-344) Submitted filename: Response to Reviewers.docx Click here for additional data file. 8 Sep 2022
PONE-D-21-38410R2
Prediction models for the prediction of unplanned hospital admissions in community-dwelling older adults: a systematic review.
PLOS ONE Dear Dr. Klunder, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 23 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Dong Keon Yon, MD, FACAAI Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: This is an excellent paper. Finally, please replace reference number 19 (PRISMA guideline 2009) with the following recent paper (PRISMA guideline 2020). DOI: https://doi.org/10.54724/lc.2022.e9 Congratulations! [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #3: I would like to thank the authors for their revised mansucript. All comments are adressed. Readability and structure have improved, making the manuscript ready for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
8 Sep 2022 Thank you for the quick and thorough review and the opportunity to publish in PLOS One. We have replaced reference number 19 with the suggested recent paper. I have uploaded the revised manuscript file. I did not include a Manuscript with Track Changes file, since MS Word does not track any changes in the reference list. If you need any additional information/files, please let me know. Submitted filename: Response to Reviewers.docx Click here for additional data file. 11 Sep 2022 Prediction models for the prediction of unplanned hospital admissions in community-dwelling older adults: a systematic review. PONE-D-21-38410R3 Dear Dr. Klunder, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Dong Keon Yon, MD, FACAAI Academic Editor PLOS ONE Additional Editor Comments (optional): This is an excellent and mesmerzing paper. Reviewers' comments: 15 Sep 2022 PONE-D-21-38410R3 Prediction models for the prediction of unplanned hospital admissions in community-dwelling older adults: a systematic review. Dear Dr. Klunder: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Dong Keon Yon Academic Editor PLOS ONE
  51 in total

1.  Trends in avoidable hospitalizations, 1980-1998.

Authors:  L J Kozak; M J Hall; M F Owings
Journal:  Health Aff (Millwood)       Date:  2001 Mar-Apr       Impact factor: 6.301

2.  Association between continuity of care in general practice and hospital admissions for ambulatory care sensitive conditions: cross sectional study of routinely collected, person level data.

Authors:  Isaac Barker; Adam Steventon; Sarah R Deeny
Journal:  BMJ       Date:  2017-02-01

Review 3.  Risk prediction in the community: A systematic review of case-finding instruments that predict adverse healthcare outcomes in community-dwelling older adults.

Authors:  Rónán O'Caoimh; Nicola Cornally; Elizabeth Weathers; Ronan O'Sullivan; Carol Fitzgerald; Francesc Orfila; Roger Clarnette; Constança Paúl; D William Molloy
Journal:  Maturitas       Date:  2015-03-20       Impact factor: 4.342

4.  PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration.

Authors:  Karel G M Moons; Robert F Wolff; Richard D Riley; Penny F Whiting; Marie Westwood; Gary S Collins; Johannes B Reitsma; Jos Kleijnen; Sue Mallett
Journal:  Ann Intern Med       Date:  2019-01-01       Impact factor: 25.391

5.  Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

Authors:  Karel G M Moons; Douglas G Altman; Johannes B Reitsma; John P A Ioannidis; Petra Macaskill; Ewout W Steyerberg; Andrew J Vickers; David F Ransohoff; Gary S Collins
Journal:  Ann Intern Med       Date:  2015-01-06       Impact factor: 25.391

6.  Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist.

Authors:  Karel G M Moons; Joris A H de Groot; Walter Bouwmeester; Yvonne Vergouwe; Susan Mallett; Douglas G Altman; Johannes B Reitsma; Gary S Collins
Journal:  PLoS Med       Date:  2014-10-14       Impact factor: 11.069

7.  What could prevent chronic condition admissions assessed as preventable in rural and metropolitan contexts? An analysis of clinicians' perspectives from the DaPPHne study.

Authors:  Jo Longman; Jennifer Johnston; Dan Ewald; Adrian Gilliland; Michael Burke; Tabeth Mutonga; Megan Passey
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

8.  Emergency department crowding: A systematic review of causes, consequences and solutions.

Authors:  Claire Morley; Maria Unwin; Gregory M Peterson; Jim Stankovich; Leigh Kinsman
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

9.  Clinically useful prediction of hospital admissions in an older population.

Authors:  Jan Marcusson; Magnus Nord; Huan-Ji Dong; Johan Lyth
Journal:  BMC Geriatr       Date:  2020-03-06       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.